This study explores the multidisciplinary fusion of Ayurveda and biotechnology as a convergent paradigm for healthcare systems. While biotechnology offers the cutting edge tools and techniques for molecular characterization, quality assurance and therapeutic innovation, Ayurveda, an ancient Indian medical tradition of healthcare, places an emphasis on personalized, preventive and holistic health practices. The study methodically investigates the biotechnological validation of Ayurvedic ideas including the use of genomes for Prakriti-based phenotyping, the clinical standardization of herbal formulations and the improvement of bioavailability. To find areas of agreement and integration issues, a qualitative review methodology was used to examine clinical research, peer-reviewed literature and regulatory frameworks. The results imply that the use of biotechnological methods can improve the safety, effectiveness, clinical efficacy and scientific legitimacy of Ayurvedic treatments. However, legal discrepancies, standardization challenges and ethical issues limit the convergence process. In the direction of changing needs for global public health, we have, through this article, endeavoured to present a systematic but evidence-based framework for combining biotechnology and Ayurvedic principles with immense potential to produce even more individualised, preventive and sustainable healthcare models.